Key result
Lacidipine slowed the progression of carotid atherosclerosis significantly more than atenolol over 4 years of treatment in hypertensive patients.
Why the study?
Does lacidipine reduce the progression of carotid atherosclerosis compared to atenolol in hypertensive patients?
Population
2,334 hypertensive patients
Comparison
Lacidipine for 4 years vs Atenolol for 4 years
Design
RCT, randomized, double-blind
Follow-up
4 years
Authors
Loading...
Supports lacidipine over atenolol to slow carotid atherosclerosis in hypertension; extends antihypertensive comparisons to vascular structural outcomes.
RCT (n=2,334)
Double-blind
Randomized
Does lacidipine reduce the progression of carotid atherosclerosis compared to atenolol in hypertensive patients?
Lacidipine slows the progression of carotid atherosclerosis significantly more than atenolol in hypertensive patients, though accurate assessment of absolute changes requires longitudinal quality control of ultrasound readings.
Zanchetti et al. (2004) conducted an RCT in Hypertension (n=2,334). Lacidipine vs. Atenolol was evaluated on Progression of carotid atherosclerosis (CBMmax). Lacidipine slowed the progression of carotid atherosclerosis significantly more than atenolol over 4 years of treatment in hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: